Glucose Measurement Multi-parameter Test System (Blood Glucose, Red Cell Volume, Ketones, Total Cholesterol, Uric Acid, Heme)
Taiwan·Risk Class 2·Taibo Technology Co., Ltd. five-stock factory·Registered Feb 06, 2024 – Jun 28, 2029Active- Analysis ID
- e550658e6d3994fa06a17576c8793d04
- Manufacturer
- Taibo Technology Co., Ltd. five-stock factory
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- TAIDOC TECHNOLOGY CORPORATION
- Intended Use
- This product is an in vitro diagnostic medical device, which is used to quantitatively detect glucose, red blood cell volume ratio, ketone body, total cholesterol and uric acid content in the blood, and can also display the calculated value of heme. Glucose, red cell volume ratio, and ketone body measurements are done using fresh fingertip microvascular whole blood or venous whole blood. Total cholesterol and uric acid are measured using fresh fingerstick microvascular whole blood. It is provided for professional or personal self-testing and is not suitable for diagnosis and screening of diseases.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1775 Uric acid testing system;; A.1345 Glucose Test System;; A.1175 Cholesterol (Total) Testing System
- Import Information
- QMS/QSD;; 國產
- Registration Date
- Feb 06, 2024
- Expiry Date
- Jun 28, 2029
Access comprehensive regulatory information for Glucose Measurement Multi-parameter Test System (Blood Glucose, Red Cell Volume, Ketones, Total Cholesterol, Uric Acid, Heme) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number e550658e6d3994fa06a17576c8793d04 and manufactured by Taibo Technology Co., Ltd. five-stock factory. The authorized representative in Taiwan is TAIDOC TECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.